-
Regulatory May 24, 2022 EnglishInitiator Pharma A/S – Resolutions of the annual general meeting 2022
-
Regulatory May 23, 2022 EnglishCorrection: Initiator Pharma reports positive efficacy data outcome of the IPTN2021 program Phase I study to assess pain-reducing effects
Share
Initiator Pharma Numbers
-
Number of men affected by Erectile Dysfunction worldwide 150 million
-
Number of people worldwide that are diagnosed with Trigeminal Neuralgia every year: 15000
-
Men with Erectile Dysfunction who do not respond to drug therapy 40 %
Initiator Pharma currently has a portfolio of four projects, of which two are in clinical development and two are in preclinical development.
CEO letter
With a plan for secured financing, an attractive portfolio of clinical assets progressing according to plan, and our latest management team member Christina Guldberg onboard as Senior Director, Clinical Development and Outcomes Research (Rare Diseases), a new position designed to strengthen our clinical development and Orphan drug capabilities, I see the future with confidence and look forward to keep you updated on our progress.
